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June Supplement 201064S Abstracts58 (55.8%) patients were note to have significant stenotic
lesions on IVUS. Among those, 10 (17.2%) patients had no
detectable lesion on venogram and would have been missed.
In 24 (41.4%), venography failed to identify all stenotic lesions
or resulted in in-accurate localization of the lesion. Only 24
(41.4%) patients had stenotic lesions on venogram that con-
formed anatomically to the lesions detected on IVUS.
Conclusions: In assessing patients with lower extrem-
ity venous stasis disease for iliac-femoral vein stenosis/
obstruction, venography alone can result in poor localiza-
tion (50% specificity) and can even miss significant stenotic
lesions (82.8% sensitivity). IVUS is a more sensitive and
accurate method, and should be included in all such evalu-
ations.
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Postoperative Morbidity and Mortality of Venous
Thrombectomy: A Review of the NSQIP Database
Eleftherios S. Xenos, Shane O’Keeffe, David Minion, Ehab
Sorial, Eric Endean. University of Kentucky and VA Med-
ical Center, Lexington, KY
Objectives: Surgical or pharmacomechanicalthrombus
removal has been shown to improve venous physiology in
acute iliofemoral deep venous thrombosis Our study fo-
cuses on the contemporary application of venous throm-
bectomy based on data from the National Surgical Quality
Improvement Program (ACS NSQIP).
Methods: Data submitted by over 200 hospitals to the
ACS NSQIP participant use file was accessed for the years
2005-2008. Patients were identified who had undergone
venous thrombectomy through leg access (Primary proce-
dure CPT 34421 or 34451). Demographic and clinical
variables along with thirty-day morbidity and mortality
were evaluated. Secondary/concomitant procedures CPT
codes were collected. Univariate analysis between groups
was performed using Chi2 or T-tests with p 0.05 consid-
ered significant.
Results: A total of 91 patients were identified who
underwent primary venous thrombectomy (67 CPT
34421, 24 CPT 34451). The mean age was 62.5  15.8 y
and 45 of 91 (49.5%) were female. Thirty-daymortality was
8.8% (8/91). Composite morbidity was 25.3% (23/91),
most frequently due to surgical site infection, and respira-
tory complications. Intraop transfusion (required in 18.7%
of the patients, was a significant predictor of postoperative
morbidity and mortality. Lower extremity fasciotomy was
performed in 8.8% of the patients and an inferior vena cava
(IVC) filter was placed in 2.2% of the patients, the incidence
of pulmonary embolism (PE) was 3.3%. An arteriovenousanastomosis was created in only one patient; venous angio-
plasty was performed in 3.3% of the patients.
Conclusions: Venous thrombectomy is associated
with significant postoperative morbidity and mortality and
should be propably limited to patients that are not candi-
cates for pharmacomechanical thrombolysis. Only two pa-
tients had an IVC filter placed during the operation but the
incidence of PE was low. Adjunctive procedures to assist
vein patency such as arteriovenous fistula creation or ve-
nous angioplasty were infrequently performed.
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neta. Vascular Surgery, Oregon Health and Sciences Uni-
versity, Portland, OR
Objectives: American Chest Physician (ACP) guide-
lines stratify DVT risk in trauma patients based on injury
pattern and use of medical prophylaxis. Screening is recom-
mended only for highest risk groups. Many screening stud-
ies for DVT did not investigated calf vein DVTs (CVDVT)
and did not exclusively target critically ill patients. Given
new ACP guidelines recommending treatment of calf vein
DVT, we investigated the efficacy of duplex ultrasound
screening (DUS) of critically ill trauma patients for all lower
extremity DVTs, including CVDVT, regardless of injury
pattern, risk factors, or medical prophylaxis.
Methods: The records of 264 intensive care unit
trauma patients who received DUS screening for lower
extremity DVT were examined for data on high-risk inju-
ries, DVT risk factors, and low molecular weight heparin
(LMWH) prophylaxis.
Results: 40 (15.2%) patients had DVTs found on DUS
screening, 25 (62.5%) were CVDVT, and 30% of all DVTs
were diagnosed within 1 week of admission. Patients without
high-risk injuries receiving LMWH had a 13.5% DVT rate,
which did not differ significantly from the 19.7% DVT rate in
high-risk injury patients not receiving LMWH (p  0.667).
Patientswithout high-risk injuries, and receivingLMWH,had
high rates of DVT even excluding other DVT risk factors.
Conclusions: Lower extremity DVT is common in crit-
ically ill trauma patients, particularly in the first week following
injury, regardless of injury pattern, DVT risk factors, or med-
ical prophylaxis. Previous studies have underestimated DVT
rates by not investigating CVDVTs. We recommend early
DVT screening of all critically ill trauma patients.
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Does Topical Wound Oxygen (TWO2) Offer an Improved
Outcome Over Conventional Compression Dressings
(CCD) in the Management of Refractory Non-healing Ve-
nous Ulcers (RVU)? Three-Year Technical and Clinical
Outcome and Midterm Results With Quality-Adjusted
Time Spent Without Symptoms of Disease and Toxicity of
Treatment (Q-TWiST)
Sherif Sultan, Wael Tawfick. Vascular & Endovascular Sur-
gery, Western Vascular Institute, Galway, Ireland
Objectives: TWO2 proposes an option in the manage-
ment of RVU. Primary endpoint is ulcer healing at 12
weeks and secondary endpoint is Q-TWiST.
Methods: 46 ulcers were managed using TWO2 ther-
apy and 37 ulcers with CCD. Demographics and risk
factors were similar in both groups. All ulcers were CEAP
C6, s.
Results: The mean reduction in ulcer surface area at 12
weeks was 96% in the TWO2 therapy group, compared to
61% in theCCDgroup.At 12weeks, 80%ofTWO2managed
ulcers were completely healed, compared to 35% of CCD
ulcers (p0.0001).Median time to full healingwas 45days in
TWO2 patients and 182days in CCD patients (p 0.0001).
32/46 of TWO2 ulcers showed reverse gradient of healing.
9/19 MRSA positive ulcers managed with TWO2 were
rendered MRSA negative after 5 weeks, compared to none
of the 17 MRSA positive CCD ulcers. The pain score
threshold in TWO2 managed patients improved from 8 to
3 by 13 days. Q-TWiST was significantly longer at 24.25
months for TWO2 and 10.5 months for CCD with p 
0.0001. After 36 months follow-up, 8 of the 13 healed
CCDulcers showed recurrence compared to none of the 37
TWO2 healed ulcers. No local or systemic complications
were encountered in either treatment group.
Conclusions: TWO2 is prudent, effective and valuable
in managing RVU up to 36 months and slashes time
needed for RVU healing. TWO2 is successful in pain
alleviation, MRSA elimination. TWO2 radically degrades
recurrence rates and thus enhances the quality of life and
has superior Q-TWiST over CCD.
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A Systematic Review on the Effectiveness of Knee Versus
Thigh Length Graduated Compression Stockings in
Thromboprophylaxis for Surgical Patients
Mital Y. Desai, Mohammed Shafique Sajid, George Ham-
ilton. Vascular Surgery, Royal FreeHampsteadNHSTrust,
London, United Kingdom
Objectives: To systematically analyze prospective ran-
domized controlled trials on effectiveness of knee (KL) vsthigh length (TL) graduated compression stockings in
thromboprophylaxis for surgical patients.
Methods: A systematic review of medical literature was
undertaken. Prospective randomized controlled trials onpostop-
erative patients of various surgical disciplines were selected ac-
cording to specific criteria. Data was extracted and analyzed by
using statistical package RevMan 5.0. Summated outcome was
calculated in form of odds ratio (OR) with 95% confidence
interval.
Results: Nine trials on 1476 patients were retrieved
from electronic databases using standardized medical sub-
ject headings. Only three trials on 498 patients qualified for
meta-analysis according to inclusion criteria. Both in fixed
[OR, 1.55; 95% CI, 0.78 - 3.07; z  1.25; p  0.21] and
random [OR, 1.33; 95% CI, 0.44 - 4.06; z  0.51; p 
0.61] effects models, KL stockings were as effective as TL
stockings for thromboprophylaxis in surgical patients.
However, there was significant heterogeneity [Chi2 
4.04, df  2, I2  50 %] among trials.
Conclusions: KL graduated compression stockings may
be as effective as TL stockings for the prevention of DVT in
surgical patients. For thromboprophylaxis, in surgical patients
KL stockings may routinely be used due to parallel efficacy,
higher patient compliance and lower cost. However, a major
randomized trial is required in order to strengthen the existing
evidence.
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Clinical Outcome Analyses of Radio-Frequency Abla-
tion (RFA) in the Treatment of Incompetent Greater
Saphenous Vein (GSV): Differences Between Closure-
Plus and ClosureFast Catheters
Natalie Marks, Enrico Ascher, Anil Hingorani, Alexsander
Shiferson, Kapil Gopal, Daniel Jung, Theresa Jacob. Divi-
sion of Vascular Services, Maimonides Medical Center,
Brooklyn, NY
Objectives: The new ClosureFast (CF) catheter has
much higher treatment speed as compared to previous Clo-
surePlus (CP) model. We compared several clinical outcomes
after use of both catheters in a large series.
Methods: From February 2005 to April 2009 there
were 656 consecutive office RFA procedures performed
first with CP and later with CF catheters. Postoperative
duplex scans (3-7days) documented technical success
(complete obliteration, partial obliteration or full patency
